Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Tech stocks pull Nifty above 8,600
Mon, 20 Jul Closing

The Indian markets end lower on concerns ahead of the monsoon session of parliament. The Sensex today ended lower by 43 points, while the NSE-Nifty ended lower by 6 points. The S&P BSE Midcap and S&P BSE Smallcap stocks ended the day higher by 0.27% and 0.4% respectively.

Asian markets finished on a mixed note at the most recent closing prices. Nikkei gained 0.25%, while the Taiwan Index lost 0.78%. The rupee was trading at 63.60 against the US$ in the post noon session.

Stocks in the cement sector ended the day on a mixed note with Ultratech Cement leading the winners. Ultratech Cement reported a 6% fall in consolidated net profit at Rs 5,910 m for the quarter ended 30th June 2015. Its consolidated net sales rose by 6% as compared to the same quarter of 2014-15 fiscal. Input prices have remained stable except for the rise in royalty for limestone and levies under the Mines and Mineral Amendment Act. Ultratech has commissioned 15 MW waste heat recovery system taking the company’s total power generation capacity from waste heat recovery to 48 MW. Stock of Ultratech Cement ended the day on a positive note.

Stocks in the pharmaceutical sector ended the day on a mixed note with Dishman Pharmaceutical leading the losers. Pharma Major Lupin, has reportedly received an approval from the USFDA for PrandiMet (also known as Prandin) generic, which is used for treatment of type 2 diabetes. The product is expected to have sales of US$ 200-300 m in the US. Danish pharma company Novo Nordisk is the innovator of the drug that has been approved to lower blood glucose in adult patients. Stock of Lupin ended the day on a positive note.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Tech stocks pull Nifty above 8,600". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.